how to transition from xtandi to Apal... - Advanced Prostate...

Advanced Prostate Cancer

22,826 members28,469 posts

how to transition from xtandi to Apalutamide?

podsart profile image
5 Replies

A change is suggested by Dr. However, Since Xtandi has a 1/2 life about 6 days, from the day you stop the amount of Xtandi starts decaying. So, Apalutamide has a half life of about 3 days, but has a fast absorption rate. This means , if you stop xtandi on day 1 and start Apalutamide on day 2, there is a period where both meds overlap in your system.

you could wait, 3-4 half life’s of xtandi for example. So, I think then you have a decay 1/2x1/2=1/4x1/2=1/8x1/2=1/16th in your body left on average, and so on. So, in this case, you have waited 3x6=18 days on avg, before starting Apalutamide. This would be a drug interaction safety approach.

on the other side of this balance beam , is your Pca safety. Assume the drug switch is due to sense that xtandi is failing to some extent. If you take a wait 3 or 4 xtandi 1/2 lives to take Apalutamide, there may be a risk that your shield against your Pca is being lowered to some extent , presumably giving your Pca a new defense hole to come through, thereby increasing danger in the cancer risk side.

So how do you find the optimal transition timing?

Written by
podsart profile image
podsart
To view profiles and participate in discussions please or .
Read more about...
5 Replies
tarhoosier profile image
tarhoosier

what does tour doctor say?

cesces profile image
cesces

You would think your doc would give good instructions. But this is the very type of thing they do poorly at.

podsart profile image
podsart in reply tocesces

thanks,sometimes true

Tall_Allen profile image
Tall_Allen

You are transitioning because Xtandi is no longer working for you, so what does it matter if both drugs are in your system temporarily? Erleada has greater AR affinity, so it hopefully will replace Xtandi at binding sites. If the concern is toxicity, monitor liver enzymes .

podsart profile image
podsart

Thanks, didnt know Erleada has greater AR affinity. Would be helpful when I talk to doc if can you direct me to the source doc re this affinity difference. Do you know if Daralutimide is even greater in its AR affinity?

Not what you're looking for?

You may also like...

Why I Like Right To Try

Lets say you have a rising PSA on Xtandi..with crossover resistance Zytiga will usually work for a...
gusgold profile image

Apalutamide - SPARTAN versus Enzalutamide - PROSPER.

Apalutamide (previously known as ARN-509) is an androgen receptor [AR] antagonist similar to...
pjoshea13 profile image

Xtandi

Well I was on Xtandi for 25 days and PSA went from 6.51 to .61 quite a fast drop! Then I had to...
roncyn profile image

What I learned from today's conference call...

This is the third year that I've listened to the CancerCare Workshop for patients called...
tallguy2 profile image

FDA Grants Priority Review to Apalutamide ...

... based on data from the phase III SPARTAN trial (ARN-509-003) News item [1]. Apalutamide may be...
pjoshea13 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.